128 related articles for article (PubMed ID: 9823452)
1. PTH(1-34) suppresses appositional bone formation by cultured rat cranial osteoblasts.
Gray C; Jones SJ
Bone; 1998 Nov; 23(5):453-7. PubMed ID: 9823452
[TBL] [Abstract][Full Text] [Related]
2. Purinergic transmitters inhibit bone formation by cultured osteoblasts.
Jones SJ; Gray C; Boyde A; Burnstock G
Bone; 1997 Nov; 21(5):393-9. PubMed ID: 9356732
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone temporal effects on bone formation and resorption.
Kroll MH
Bull Math Biol; 2000 Jan; 62(1):163-88. PubMed ID: 10824426
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment with vitamin K2 and PTH enhanced bone formation in ovariectomized rats and increased differentiation of osteoblast in vitro.
Weng SJ; Yan DY; Gu LJ; Chen L; Xie ZJ; Wu ZY; Tang JH; Shen ZJ; Li H; Bai BL; Boodhun V; Yang L
Chem Biol Interact; 2019 Feb; 300():101-110. PubMed ID: 30639440
[TBL] [Abstract][Full Text] [Related]
5. Topical and intermittent application of parathyroid hormone recovers alveolar bone loss in rat experimental periodontitis.
Tokunaga K; Seto H; Ohba H; Mihara C; Hama H; Horibe M; Yoneda S; Nagata T
J Periodontal Res; 2011 Dec; 46(6):655-62. PubMed ID: 21722135
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells.
Ishizuya T; Yokose S; Hori M; Noda T; Suda T; Yoshiki S; Yamaguchi A
J Clin Invest; 1997 Jun; 99(12):2961-70. PubMed ID: 9185520
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone reversibly suppresses the differentiation of osteoprogenitor cells into functional osteoblasts.
Bellows CG; Ishida H; Aubin JE; Heersche JN
Endocrinology; 1990 Dec; 127(6):3111-6. PubMed ID: 2174346
[TBL] [Abstract][Full Text] [Related]
8. Identification of a PTH regulated gene selectively induced in vivo during PTH-mediated bone formation.
Robinson JA; Susulic V; Liu YB; Taylor C; Hardenburg J; Gironda V; Zhao W; Kharode Y; McLarney S; Bai Y; Malone DP; Murrills R; Bex F
J Cell Biochem; 2006 Aug; 98(5):1203-20. PubMed ID: 16514668
[TBL] [Abstract][Full Text] [Related]
9. Different duration of parathyroid hormone exposure distinctively regulates primary response genes Nurr1 and RANKL in osteoblasts.
Choi H; Magyar CE; Nervina JM; Tetradis S
PLoS One; 2018; 13(12):e0208514. PubMed ID: 30576321
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of high dietary calcium and exogenous parathyroid hormone in promoting osteoblastic bone formation in mice.
Feng Y; Zhou M; Zhang Q; Liu H; Xu Y; Shu L; Zhang J; Miao D; Ren Y
Br J Nutr; 2015 Mar; 113(6):909-22. PubMed ID: 25744000
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone (1-34) regulates integrin expression in vivo in rat osteoblasts.
Kaiser E; Sato M; Onyia JE; Chandrasekhar S
J Cell Biochem; 2001; 83(4):617-30. PubMed ID: 11746505
[TBL] [Abstract][Full Text] [Related]
12. Intermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblasts.
Jilka RL; O'Brien CA; Ali AA; Roberson PK; Weinstein RS; Manolagas SC
Bone; 2009 Feb; 44(2):275-86. PubMed ID: 19010455
[TBL] [Abstract][Full Text] [Related]
13. Modulation of osteogenic cell ultrastructure by RS-23581, an analog of human parathyroid hormone (PTH)-related peptide-(1-34), and bovine PTH-(1-34).
Leaffer D; Sweeney M; Kellerman LA; Avnur Z; Krstenansky JL; Vickery BH; Caulfield JP
Endocrinology; 1995 Aug; 136(8):3624-31. PubMed ID: 7628402
[TBL] [Abstract][Full Text] [Related]
14. Short-term intermittent PTH 1-34 administration enhances bone formation in SCID/Beige mice.
Sheehan S; Muthusamy A; Paul E; Sikes RA; Gomes RR
Endocr J; 2010; 57(5):373-82. PubMed ID: 20139633
[TBL] [Abstract][Full Text] [Related]
15. 3',5'-Cyclic adenosine monophosphate activation in osteoblastic cells: effects on parathyroid hormone-1 receptors and osteoblastic differentiation in vitro.
Koh AJ; Beecher CA; Rosol TJ; McCauley LK
Endocrinology; 1999 Jul; 140(7):3154-62. PubMed ID: 10385409
[TBL] [Abstract][Full Text] [Related]
16. The effects of low dose parathyroid hormone on lumbar vertebrae in a rat model for chronic alcohol abuse.
Howe KS; Iwaniec UT; Turner RT
Osteoporos Int; 2011 Apr; 22(4):1175-81. PubMed ID: 20549487
[TBL] [Abstract][Full Text] [Related]
17. Changes in osteoblast, chondrocyte, and adipocyte lineages mediate the bone anabolic actions of PTH and small molecule GSK-3 inhibitor.
Kulkarni NH; Wei T; Kumar A; Dow ER; Stewart TR; Shou J; N'cho M; Sterchi DL; Gitter BD; Higgs RE; Halladay DL; Engler TA; Martin TJ; Bryant HU; Ma YL; Onyia JE
J Cell Biochem; 2007 Dec; 102(6):1504-18. PubMed ID: 17520664
[TBL] [Abstract][Full Text] [Related]
18. Involvement of dual signal transduction systems in the stimulation of osteoclast-like cell formation by parathyroid hormone and parathyroid hormone-related peptide.
Kaji H; Sugimoto T; Kanatani M; Fukase M; Chihara K
Biochem Biophys Res Commun; 1993 Jul; 194(1):157-62. PubMed ID: 8392835
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of TIMP-1 in osteoblasts increases the anabolic response to PTH.
Merciris D; Schiltz C; Legoupil N; Marty-Morieux C; de Vernejoul MC; Geoffroy V
Bone; 2007 Jan; 40(1):75-83. PubMed ID: 16949899
[TBL] [Abstract][Full Text] [Related]
20. Expression of Rho GDIalpha in rat osteoblasts intermittently exposed to parathyroid hormone in vitro and in vivo.
Sun ZF; Jiang H; Ye ZQ; Jia B; Zhang XL; Zhang KQ
Acta Pharmacol Sin; 2009 Jul; 30(7):1001-7. PubMed ID: 19575003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
